CS logo
small CS logo
Division of Pediatric Endocrinology and Diabetes, Stanford University

Stanford, California, United States

About Division of Pediatric Endocrinology and Diabetes, Stanford University


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Division of Pediatric Endocrinology and Diabetes, Stanford University


During the past decade, Division of Pediatric Endocrinology and Diabetes, Stanford University conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Division of Pediatric Endocrinology and Diabetes, Stanford University" #1 collaborator was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 10 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Division of Pediatric Endocrinology and Diabetes, Stanford University


According to Clinical.Site data, the most researched conditions in "Division of Pediatric Endocrinology and Diabetes, Stanford University" are "Diabetes Mellitus, Insulin-Dependent" (4 trials), "Diabetes Mellitus, Type I" (3 trials), "Type 1 Diabetes" (2 trials) and "Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Division of Pediatric Endocrinology and Diabetes, Stanford University" in a lesser frequency.

Clinical Trials Intervention Types at Division of Pediatric Endocrinology and Diabetes, Stanford University


Most popular intervention types in "Division of Pediatric Endocrinology and Diabetes, Stanford University" are "Device" (5 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Continuous Glucose Monitoring System (CGMS)" (2 trials), "GlucoWatch® G2™ Biographer (GW2B)" (2 trials), "Continuous Glucose Monitoring System™ (CGMS)" (1 trials), "FreeStyle Navigator Continuous Glucose Monitoring System" (1 trials) and "GlucoWatch G2TM Biographer (GW2B)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Division of Pediatric Endocrinology and Diabetes, Stanford University


The vast majority of trials in "Division of Pediatric Endocrinology and Diabetes, Stanford University" are 10 trials for "All" genders.

Clinical Trials Status at Division of Pediatric Endocrinology and Diabetes, Stanford University


Currently, there are NaN active trials in "Division of Pediatric Endocrinology and Diabetes, Stanford University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Division of Pediatric Endocrinology and Diabetes, Stanford University, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Division of Pediatric Endocrinology and Diabetes, Stanford University, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".